The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population.
The market is segmented on the basis of product, usability, vessel type, application, and region. On the basis of product, the global market is segmented into EVH systems, endoscopes, and accessories. The EVH systems segment accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. This can be primarily attributed to the rising adoption of minimally invasive procedures for vessel harvesting and disposable nature of these products.
Based on usability, the market is segmented into disposable and reusable. In 2017, the disposable segment commanded the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period primarily due to the rising preference for disposable devices over reusable owing to the advantages offered.
Based on vessel type, the market is segmented into saphenous vein and radial artery. The saphenous vein segment is expected to register highest CAGR during the forecast period. This can be attributed to the advantages offered by saphenous vein in terms of wound complications, reduced pain, and aesthetics.
Based on application, the market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment is expected to register the highest CAGR during the forecast period primarily due to the rising prevalence of cardiovascular diseases and increasing geriatric population.
The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high burden of cardiovascular diseases (CVDs), the launch of the Hospital Readmissions Reduction Program (HRRP) and Episode-based Payment Models (EPMs), increasing incidence of cardiac diseases, and growing preference for minimally invasive harvesting procedures.
The availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH is expected to restrain the growth of this market during the forecast period.
The major players in this market include Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
No comments:
Post a Comment